在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Granulins(GRN) ELISA kit

  • 中文名稱:
    人顆粒體蛋白 (GRN)酶聯免疫試劑盒
  • 貨號:
    CSB-EL009939HU
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人顆粒體蛋白 (GRN)酶聯免疫試劑盒(CSB-EL009939HU)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織培養上清液樣本中的GRN含量。GRN即顆粒溶素基因,其表達的顆粒溶素是一種具有抗菌、抗病毒及抗腫瘤活性的蛋白。研究機制上,它可通過形成孔道破壞病原體膜結構,還能誘導腫瘤細胞凋亡、調節免疫反應等,在感染性疾病和癌癥治療研究中頗具潛力。試劑盒檢測范圍為7.8 pg/mL-500 pg/mL,適用于科研場景中GRN表達水平的動態監測,例如探究神經退行性疾病模型、炎癥相關細胞實驗或藥物干預研究中GRN的調控機制,為疾病分子機制探索及生物標志物分析提供可靠工具本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Acrogranin ELISA Kit; CLN11 ELISA Kit; GEP ELISA Kit; GP88 ELISA Kit; Granulin A ELISA Kit; Granulin B ELISA Kit; Granulin C ELISA Kit; Granulin D ELISA Kit; Granulin E ELISA Kit; Granulin epithelin ELISA Kit; Granulin F ELISA Kit; Granulin G ELISA Kit; Granulin-7 ELISA Kit; Granulins ELISA Kit; GRN ELISA Kit; GRN_HUMAN ELISA Kit; PC cell derived growth factor ELISA Kit; PCDGF ELISA Kit; PEPI ELISA Kit; PGRN ELISA Kit; Proepithelin ELISA Kit; Progranulin ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, cell culture supernates
  • 檢測范圍:
    7.8 pg/mL-500 pg/mL
  • 靈敏度:
    1.95 pg/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Neuroscience
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human GRN in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)
    1:1000 Average % 84
    Range % 81-86
    1:2000 Average % 85
    Range % 82-89
    1:4000 Average % 104
    Range % 101-107
    1:8000 Average % 89
    Range % 85-93
  • 回收率:
    The recovery of human GRN spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 95 92-98
    EDTA plasma (n=4) 105 101-109
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/ml OD1 OD2 Average Corrected
    500 1.943 2.105 2.024 1.942
    250 1.566 1.530 1.548 1.466
    125 1.019 1.111 1.065 0.983
    62.5 0.691 0.705 0.698 0.616
    31.2 0.410 0.431 0.421 0.339
    15.6 0.256 0.241 0.249 0.167
    7.8 0.178 0.168 0.173 0.091
    0 0.081 0.083 0.082  
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    Secreted protein that acts as a key regulator of lysosomal function and as a growth factor involved in inflammation, wound healing and cell proliferation. Regulates protein trafficking to lysosomes and, also the activity of lysosomal enzymes. Facilitates also the acidification of lysosomes, causing degradation of mature CTSD by CTSB. In addition, functions as wound-related growth factor that acts directly on dermal fibroblasts and endothelial cells to promote division, migration and the formation of capillary-like tubule structures. Also promotes epithelial cell proliferation by blocking TNF-mediated neutrophil activation preventing release of oxidants and proteases. Moreover, modulates inflammation in neurons by preserving neurons survival, axonal outgrowth and neuronal integrity.; Promotes proliferation of the epithelial cell line A431 in culture.; Inhibits epithelial cell proliferation and induces epithelial cells to secrete IL-8.; Stabilizes CTSD through interaction with CTSD leading to maintain its aspartic-type peptidase activity.
  • 基因功能參考文獻:
    1. progranulin reduction might be the cause of multiple proteinopathies due to the accelerating accumulation of abnormal proteins including TDP-43 proteinopathy, tauopathy and alpha-synucleinopathy. PMID: 28473694
    2. Results suggest that serum PGRN levels are significantly higher in obese children in China and correlate significantly with obesity-related markers. Increased PGRN levels may be involved in the pathological mechanism of childhood obesity. PMID: 30151059
    3. Progranulin has a direct effect on tumor growth, migration, and invasion of human colon cancer cells. It may serve as a potential therapeutic target for human colon cancer. PMID: 30060789
    4. Accumulating evidence suggests that PGRN is essential for proper lysosomal function, but the precise mechanisms involved are not known. Here, we show that PGRN facilitates neuronal uptake and lysosomal delivery of prosaposin (PSAP), the precursor of saposin peptides that are essential for lysosomal glycosphingolipid degradation. PMID: 28541286
    5. miR-29b-3p bound to PGRN in a direct manner. Transfection with si-PGRN correlated with elevated E-cadherin expression, decreased snail and vimentin expressions, as well as less-motivated cell proliferation and cell metastasis. The H19/miR-29b-3p/PGRN axis modulated epithelial-mesenchymal transition of NSCLC cells via Wnt/beta-catenin signaling. PMID: 29754471
    6. SNPs in GRN are not related to ankylosing spondylitis susceptibility in a Chinese Han population. PMID: 29230494
    7. Plasma progranulin levels predict the presence of GRN null mutations independent of proximity to symptoms and brain atrophy. PMID: 29146050
    8. Serum progranulin may have potential to be used as a biomarker for the differentiation between early-onset pre-eclampsia and late-onset pre-eclampsia. PMID: 28574293
    9. CHI3L1 may be a previously unrecognized biomarker for diagnosing Gaucher Diseases (GD) and for evaluating the therapeutic effects of new GD drug. PMID: 29396296
    10. The increased serum progranulin concentrations were closely related to measures of adiposity, metabolic parameters, inflammatory marker and insulin resistance indices, suggesting that progranulin may be an excellent biomarker for obesity in childhood. PMID: 29176029
    11. This work identifies PGRN as an activator of lysosomal cathepsin D activity, and suggests that decreased cathepsin D activity due to loss of PGRN contributes to both FTD and NCL pathology in a dose-dependent manner. PMID: 29036611
    12. MiR-29b-3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN. PMID: 28609022
    13. Results provide evidence that progranulin destabilizes sortilin via ubiquitination and lysosomal degradation to override the negative modulatory functions of sortilin thereby assuring the sustainable pro-tumorigenic actions of progranulin in castration-resistant prostate cancer. PMID: 28433812
    14. PGRN is a regulator of tumorigenesis because it stimulates cell proliferation, migration, invasion, angiogenesis, malignant transformation, resistance to anticancer drugs, and immune evasion. [review] PMID: 29116422
    15. PGRN regulated its own expression in a positive feedback loop via the AKT and ERK signaling pathways. PMID: 29039535
    16. PGRN is involved in lysosomal homeostasis and lipid metabolism. PMID: 28903038
    17. High serum GP88 concentrations are associated with poor prognosis in patients with DLBCL PMID: 28823651
    18. This study showed that endogenous levels of multiple GRNs are haploinsufficient in FTD-GRN patient fibroblasts and frontal cortex, mirroring full-length PGRN. PMID: 28828399
    19. HSPA5 (GRP78) and GEP were identified to interact. Clinical analysis showed that expression of GRP78 was up-regulated in hepatocellular carcinoma tumor and correlated with GEP expression. PMID: 28601093
    20. the expression of PGRN was significantly upregulated in Osteonecrosis of the Femoral Head patients' articular cartilage, and recombinant PGRN could promote expression of aggrecan and collagen II and the activation of ERK1/2. PMID: 28247166
    21. White matter hyperintensities are seen only in GRN mutation carriers in fronto-temporal dementia. PMID: 28529873
    22. The study provides solid evidence that there is the interaction between GRN A and ENO1 and the interaction is responsible for the effects of GRN A on glucose uptake as well as cancer cell migration and invasion. PMID: 28415822
    23. This study ascertained that PGRN expression in airway epithelial cells inhibits CS-induced apoptosis, presumably through regulation of the ER stress response and MAPK activation. PMID: 28273689
    24. This study describe a novel GRN, p.(Tyr229*) mutation, resulting in haploinsufficiency of GRN and a severe neuropathologic FTLD phenotype. PMID: 27767988
    25. This meta-analysis supported the T allele of rs5848 within progranulin, as a risk factor for Alzheimer's Disease. PMID: 26820675
    26. Our case report further corroborates the notion that, in addition to FTD, progranulin may be involved in the neurobiology of bipolar disorder type 1, and suggests to screen patients with late-onset bipolar disorder for GRN mutations. PMID: 28664756
    27. GRN SNPs likely influence disease course and relapse recovery in multiple sclerosis. PMID: 26447062
    28. This study revealed no patients presenting with typical clinical PSPS to have evidence of GRN mutations producing TDP-43 pathology. PMID: 27163816
    29. This study reported a novel pathogenic splice site mutation in GRN (c.709-2 A>T) causative for FTD and we show that 1) GRN LoF mutations are a rare cause of FTD in this Italian cohort. PMID: 27258413
    30. progranulin expression is critical for tumor growth in vivo, in both xenograft and orthotopic tumor models PMID: 27220888
    31. results revealed an important role of NF-kappaB signalling in PGRN-associated frontotemporal lobar degeneration-DNA-binding protein 43 and confirm that PGRN can bind to TNF-alpha receptors regulating the expression of WNT5A, suggesting novel targets for treatment of frontotemporal lobar degeneration-DNA-binding protein linked to GRN mutations. PMID: 26624524
    32. These results suggest an important role of Wnt activation inducing cell cycle disturbance-mediated neuronal loss in the pathogenesis of PGRN deficiency-linked frontotemporal lobar degeneration with TDP-43 protein inclusions. PMID: 26676574
    33. Study demonstrate that PGRN interacts with the lysosomal protease CTSD and maintains its proper activity in vivo. Therefore, by regulating CTSD activity, PGRN may modulate protein homeostasis. This could potentially explain the TDP-43 aggregation observed in frontotemporal lobar degeneration with GRN mutations. PMID: 28493053
    34. Data indicate significant correlation of granulin-epithelin precursor (GEP) with beta-catenin in hepatocellular carcinoma (HCC) cohort. PMID: 26942873
    35. We identified 3 novel GRN mutations (p.Q130X, p.317Afs*12, and p.K259Afs*23) in patients diagnosed with nonfluent-variant PPA or behavioral-variant FTD. The frequency of GRN mutations was 9.6% and that of MAPT mutations was 7.1%. Among familial cases of FTD, the frequency of GRN mutations was 31.5% and that of MAPT mutations was 10.5% in Brazil. PMID: 27082848
    36. Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration. PMID: 28285794
    37. existence of a founder effect for C157KfsX97 mutation in patients with frontotemporal lobar degeneration inSouthern Italy. PMID: 27814992
    38. GRN gene deletion is genetic etiology of familial frontotemporal dementia. PMID: 28153380
    39. Thisstudy has demonstrated the effect of inflammatory cytokine on cartilage graft as well as the protective role of PGRN on this graft. Without the anti-inflammatory effect from PGRN, hyaline cartilaginous extracellular matrices in living hyaline cartilage graft constructs could be easily remodeled into fibrotic or mineralized tissue and would no longer be able to fulfil the role of a cartilage graft. PMID: 27465877
    40. This study demonstrated that the GRN mutation carriers showed significant frontoparietal hypoperfusion compared with controls at follow-up. PMID: 27625986
    41. The GRN risk SNP (rs5848) was associated with variation in detected levels of CSF proteins previously implicated in CNS inflammation. The same GRN risk allele was also associated with increased CSF tau which may indicate directly related neurodegenerative changes. PMID: 28189700
    42. Granulin is deposited in specific brain regions that differ between Alzheimer's disease patients and Frontotemporal lobar degeneration patients. PMID: 29044416
    43. Mutation of GRN is a common cause of FTD in mainland China. PMID: 27311648
    44. the influence of the p.A152T MAPT variant on the clinical and neuropathological features of these Basque GRN families, is reported. PMID: 28594853
    45. Results indicate that central nervous progranulin reduction is not restricted to the relatively rare cases of frontotemporal dementia caused by progranulin gene (GRN) loss of function mutations, but also contributes to the more common GRN-negative forms of frontotemporal dementia. PMID: 27760429
    46. a complete screening for mutations in MAPT, GRN and C9ORF72 genes revealed a frequency of 5.4% of pathogenic mutations in a random cohort of 93 Turkish index patients with dementia PMID: 27632209
    47. This Progress article reviews recent advances in progranulin biology emphasizing its roles in lysosomal function and brain innate immunity, and outlines future avenues of investigation that may lead to new therapeutic approaches for neurodegeneration--{REVIEW} PMID: 28435163
    48. serum progranulin levels had a positive correlation with pulmonary function in patients with asthma and a negative correlation with blood neutrophil counts. PMID: 28073702
    49. Progranulin (PGRN), a 593-amino-acid autocrine growth factor has multiple functions involved in cell proliferation, wound healing, neurodegeneration, insulin resistance, and tumorigenesis. PMID: 27149013
    50. progranulin is affected by a decrease in eGFR, being at a higher concentration in serum and lower in urine of DKD patients with T2DM and eGFR <60 mL/min/1.73m2. It is also associated with markers of obesity and inflammation PMID: 27776152

    顯示更多

    收起更多

  • 相關疾病:
    Ubiquitin-positive frontotemporal dementia (UP-FTD); Ceroid lipofuscinosis, neuronal, 11 (CLN11)
  • 亞細胞定位:
    Secreted. Lysosome.
  • 蛋白家族:
    Granulin family
  • 組織特異性:
    In myelogenous leukemic cell lines of promonocytic, promyelocytic, and proerythroid lineage, in fibroblasts, and very strongly in epithelial cell lines. Present in inflammatory cells and bone marrow. Highest levels in kidney.
  • 數據庫鏈接:

    HGNC: 4601

    OMIM: 138945

    KEGG: hsa:2896

    STRING: 9606.ENSP00000053867

    UniGene: Hs.514220



主站蜘蛛池模板: 国产精品一区二区手机在线观看| 精品国产免费一区二区三区| 国产一区二区怡红院| 亚洲第一天堂无码专区| 少妇大叫好爽受不了午夜视频| 国内精品自在自线| 很色很爽很黄裸乳视频| 99精品国产丝袜在线拍国语| 7777久久久国产精品消防器材| 亚洲精华国产精华精华液网站| 又粗又硬整进去好爽视频| 国产ktv交换配乱婬视频| 99精品视频在线观看免费蜜桃| 色欲色香天天天综合网www| 国产精品刮毛| 国产亚洲熟妇综合视频| 国产熟女高潮视频| 久久精品天天中文字幕人妻| 大帝av在线一区二区三区| 亚洲欧洲日产国码无码网站| 久久亚洲国产成人精品无码区| 久久久久国产综合av天堂| 老师黑色丝袜被躁翻了av| 欧美日产国产精品日产| 国产成人精品亚洲日本在线| 在线无码中文字幕一区| 老司机午夜精品视频资源| 露脸叫床粗话东北少妇| 久久人人爽人人爽人人片av高请| 久久99精品国产自在现线小黄鸭 | 性生交大片免费看l| 欧美国产伦久久久久久久| 曰批视频免费30分钟成人| 欧洲精品码一区二区三区| 在线 偷窥 制服 另类| 成人免费无码大片a毛片18| 久久久久久久综合色一本| 香港日本三级亚洲三级| 在教室伦流澡到高潮h麻豆| 成人小说亚洲一区二区三区| 久久精品国产最新地址|